FDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Breast CancerGenitourinary CancerLung CancerLymphoma & Plasma Cell DisordersMultiple MyelomaOncologyHematology
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Multiple MyelomaAMLBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Surveillance after testicular cancer: New approaches slash radiation exposureFebruary 25, 2021Genitourinary CancerOncology
How has the pandemic affected rural and urban cancer patients?February 18, 2021Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
CCR score can guide treatment decisions after radiation in prostate cancerFebruary 13, 2021Genitourinary CancerProstate CancerOncology
Liquid vs. tissue biopsy in advanced prostate cancer: Why not both?February 12, 2021Genitourinary CancerOncology
Declines in PSA screening may account for rise in metastatic prostate cancersFebruary 12, 2021Genitourinary CancerOncologyProstate Cancer
Managing cancer outpatients during the pandemic: Tips from MSKCCFebruary 8, 2021Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaOncology
Aspirin linked to reduced bladder, breast cancer mortalityFebruary 2, 2021Breast CancerGenitourinary CancerOncology
COVID-19 vaccination in cancer patients: NCCN outlines prioritiesFebruary 1, 2021Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Model predicts acute kidney injury in cancer patients a month in advanceFebruary 1, 2021Genitourinary CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerBreast Cancer
U.S. cancer death rates drop for second year in a rowJanuary 14, 2021Lung CancerBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersOncology
Study shows no link between race and mortality in clear cell RCCDecember 17, 2020Genitourinary CancerOncology
FDA approves first agent for PSMA-PET imaging in prostate cancerDecember 2, 2020Genitourinary CancerProstate CancerOncology
